Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Share data, unless otherwise specified	6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Rights, Outstanding at beginning of period	446,000
Number of Rights, Exercised	(94,000)
Number of Rights, Granted	0	0
Number of Rights, Forfeited	(5,000)
Number of Rights, Outstanding at end of period	347,000
Number of Rights, Exercisable and vested at end of period	50,000
Number of Rights, Vested and expected to vest at end of period	340,000
Weighted Average Exercise Price, Outstanding at beginning of period	$ 60.55
Weighted Average Exercise Price, Exercised	$ 50.66
Weighted Average Exercise Price, Granted	$ 0.00
Weighted Average Exercise Price, Forfeited	$ 63.50
Weighted Average Exercise Price, Outstanding at end of period	$ 63.18
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 56.26
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 63.15
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 4 months 24 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	2 years 2 months 9 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 4 months 21 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 2,088
Aggregate Intrinsic Value, Exercisable and vested at end of period	644
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 2,057